offline
Abbott (ABT) Q3 Earnings and Revenues Beat Estimates
Abbott (ABT) came out with quarterly earnings of $1.40 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.98 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 52.17%. A quarter ago, it was expected that this maker of infant formula, medical devices and drugs would post earnings of $1.01 per share when it actually produced earnings of $1.17, delivering a surprise of 15.84%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Abbott, which belongs to the Zacks Medical - Products industry, posted revenues of $10.93 billion for the quarter ended September 2021, surpassing the Zacks Consensus Estimate by 15.30%. This compares to year-ago revenues of $8.85 billion.
...
https://finance.yahoo.com/news/abbott-ab...12086.html
![[Bild: ABTd070818937i.png]](https://finviz.com/publish/102121/ABTd070818937i.png)
Abbott (ABT) came out with quarterly earnings of $1.40 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.98 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 52.17%. A quarter ago, it was expected that this maker of infant formula, medical devices and drugs would post earnings of $1.01 per share when it actually produced earnings of $1.17, delivering a surprise of 15.84%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Abbott, which belongs to the Zacks Medical - Products industry, posted revenues of $10.93 billion for the quarter ended September 2021, surpassing the Zacks Consensus Estimate by 15.30%. This compares to year-ago revenues of $8.85 billion.
...
https://finance.yahoo.com/news/abbott-ab...12086.html
__________________
